Skip to main content
. 2022 Oct 7;13:998499. doi: 10.3389/fendo.2022.998499

Table 1.

Baseline characteristics of patients with or without stress hyperglycaemia on admission.

Total (n = 1792) No stress hyperglycaemia (n = 1293) Stress hyperglycaemia (n = 499) P
Age, years, median (25th-75th percentile) 47 (38-57) 47 (39-58) 46 (38-54) 0.094
Sex, male, n (%) 1135 (63.3) 807 (62.4) 328 (65.7) 0.191
BMI, median (25th-75th percentile) 24.24 (22.03-26.86) 24.03 (21.8-26.37) 25.16 (22.77-27.68) <0.001
Charlson comorbidity index, median (25th-75th percentile) 0 (0-1) 0 (0-1) 0 (0-2) 0.003
Pre-existing DM, n (%) 245 (13.7) 176 (13.6) 69 (13.8) 0.905
Referral, n (%) 907 (50.6) 627 (48.5) 280 (56.1) 0.004
Time to admission, days, median (25th-75th percentile) 1 (1-2) 1 (1-2) 1 (1-2) 0.17
Aetiology, n (%)
 Biliary 696 (38.8) 543 (42.0) 153 (30.7) <0.001
 HTG-associated 486 (27.1) 300 (23.2) 186 (37.3) <0.001
 Alcohol excess 161 (9.0) 118 (9.1) 43 (8.6) 0.736
 Others or unknown 449 (25.1) 332 (25.7) 117 (23.4) 0.329
Admission glucose and lipid levels, median (25th-75th percentile)
 Blood glucose, mmol/L 8.06 (6.38-11.61) 7.08 (5.9-8.5) 12.99 (11.24-17.25) <0.001
 Triglycerides, mmol/L 2.65 (1.04-10.84) 2.77 (0.95-8.24) 6.05 (1.52-14.82) <0.001
Admission clinical severity scores, median (25th-75th percentile)
 SIRS 2 (1-2) 1 (1-2) 2 (1-3) <0.001
 APACHE II 6 (3-8) 5 (3-8) 7 (4-10) <0.001

P for Mann–Whitney U test or Chi-square test of comparison between no stress hyperglycaemia and stress hyperglycaemia groups.

BMI, body mass index; DM, diabetes mellitus; HTG, hypertriglyceridaemia; SIRS, Systemic Inflammatory Response Syndrome; APACHE II, Acute Physiology and Chronic Health Evaluation II.

Bold values indicates that the P value is statistically significant.